Metformin and Nicotine Interaction Profile: What Patients and Prescribers Need to Know

Is nicotine listed as a metformin interaction?

No. The metformin hydrochloride tablet label has a drug interaction table covering five groups: carbonic anhydrase inhibitors such as topiramate, zonisamide, acetazolamide and dichlorphenamide; drugs that reduce metformin clearance through the OCT2/MATE transporters (ranolazine, vandetanib, dolutegravir, cimetidine); alcohol; insulin and insulin secretagogues; and drugs that can raise blood glucose, including thiazides, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers and isoniazid [1]. Nicotine and tobacco are not among them [1].

One entry is easy to misread. The label lists nicotinic acid, which is a different compound from nicotine.

Why the usual smoking interaction skips metformin

Most smoking-drug interactions are about liver enzymes, not nicotine. Polycyclic aromatic hydrocarbons in tobacco smoke induce CYP1A2 in the liver [7][2]. Nicotine itself is not the inducer, and nicotine replacement does not reproduce the effect [3].

The main drugs affected by CYP1A2 induction are CYP1A2 substrates such as caffeine, clozapine, fluvoxamine, olanzapine, tacrine and theophylline [2]. Metformin is not metabolized, has no metabolites, and is excreted unchanged in urine by tubular secretion, with a plasma half-life of about 6.2 hours [1].

The size of the CYP1A2 effect, for contrast: caffeine half-life was 3.5 hours in 13 smokers versus 6.0 hours in 13 non-smokers, with clearance of 155 versus 94 mL/kg/h [8]. When 12 heavy smokers stopped, caffeine clearance fell 36.1%, from 2.47 to 1.53 mL/min/kg, with a half-life of the decline of 38.6 hours [9].

Does nicotine affect blood sugar control?

The studies below measured insulin action, and the results differ [5][6][10].

Attvall and colleagues studied 7 healthy smokers who used at least 20 cigarettes a day for at least 5 years, using a euglycemic clamp. Smoking one cigarette per hour for 6 hours impaired insulin action (P<0.05), mainly through lower peripheral glucose uptake; taking snuff, which produced similar plasma nicotine levels, did not [5].

Eliasson and colleagues compared 20 long-term users of nicotine chewing gum with 20 matched non-users and found insulin resistance and hyperinsulinemia, with insulin sensitivity correlating inversely with plasma cotinine [10].

The largest dataset points the other way. In the Insulin Resistance Atherosclerosis Study, insulin sensitivity was measured directly in 1,481 adults: active smoking was not associated with insulin sensitivity, while exposure to secondhand smoke was (p=0.019) [6].

What changes when someone stops smoking

Quitting reverses CYP1A2 induction, and doses of theophylline, clozapine, olanzapine and warfarin may need adjusting [3]. Metformin is not on that list; it is not metabolized [1].

Lactic acidosis: what the label warns about

The boxed warning is the main safety fact for anyone taking metformin. The risk factors it names include renal impairment, certain interacting drugs, age 65 or older, radiologic studies with contrast, surgery and other procedures, hypoxic states such as acute congestive heart failure, excessive alcohol intake, hepatic impairment and, in the immediate-release label, mitochondrial diseases [1]. Smoking and COPD are not named; hypoxia is, and the label's own example is heart failure [1].

The warning describes a subtle onset with malaise, myalgias, respiratory distress, somnolence and abdominal pain, and a laboratory picture of lactate above 5 mmol/L, anion gap acidosis and metformin levels generally above 5 mcg/mL [1]. If lactic acidosis is suspected, the label says to stop metformin, give supportive care in hospital and use prompt hemodialysis [1].

Renal function sets the practical limits. The label says to check eGFR before starting and at least yearly. Metformin is contraindicated below 30 mL/min/1.73 m2, starting is not recommended at 30 to 45, and if eGFR falls below 45 the label says to reassess benefit and risk [1].